Home > Insider Trading > Filing (0001062993-24-016173)

Filing Details

Accession Number:: 0001062993-24-016173
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-04 20:24:59
Reporting Period:: 2024-09-01

Accepted Time:: 2024-09-04 20:24:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
12208	Bio-Rad Laboratories Inc.	BIO BIOB	Laboratory Analytical Instruments (3826)	941381833

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2022345	James Barry	C/O Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules CA 94547	Evp, President, Lsg	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Bio-Rad A Common Stock	Acquisiton	2024-09-01	250	$0.00	327	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2024-09-01	90	$337.32	237	No	4	F	Direct
Bio-Rad A Common Stock	Acquisiton	2024-09-01	173	$0.00	410	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2024-09-01	62	$337.32	348	No	4	F	Direct
Bio-Rad A Common Stock	Acquisiton	2024-09-01	177	$0.00	525	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2024-09-01	64	$337.32	461	No	4	F	Direct
Bio-Rad A Common Stock	Acquisiton	2024-09-02	265	$0.00	726	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2024-09-02	95	$337.32	631	No	4	F	Direct
Bio-Rad A Common Stock	Acquisiton	2024-09-03	217	$0.00	848	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2024-09-03	78	$334.31	770	No	4	F	Direct
Bio-Rad A Common Stock	Disposition	2024-09-04	623	$330.49	147	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Bio-Rad A Common Stock	Restricted Stock Units	Disposition	2024-09-01	250	$0.00	250	$0.00
Bio-Rad A Common Stock	Restricted Stock Units	Disposition	2024-09-01	173	$0.00	173	$0.00
Bio-Rad A Common Stock	Restricted Stock Units	Disposition	2024-09-01	177	$0.00	177	$0.00
Bio-Rad A Common Stock	Restricted Stock Units	Disposition	2024-09-02	265	$0.00	265	$0.00
Bio-Rad A Common Stock	Restricted Stock Units	Disposition	2024-09-03	217	$0.00	217	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
752	No	4	M	Direct
348	No	4	M	Direct
178	No	4	M	Direct
0	No	4	M	Direct
0	No	4	M	Direct

Footnotes

Shares of Class A common stock acquired on the vesting of restricted stock units.
Includes 45.6820 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.40 to $330.63, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.